The Modesto Bee Local Stock Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ENDOCYTE (NQ: ECYT)
14.38 USD  +0.12 (+0.84%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News
Stories about ENDOCYTE
 
< Previous 1 2 3 Next >
Endocyte, Inc. (ECYT) Posts Q1 Loss of 11c/Share
May 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8301176 for the full story. Read More
from StreetInsider.com News Articles
American Real Disposable Income Collapses in First Quarter of 2013
April 30, 2013
category Pharmaceuticals , Exchanges
from Trefis
Endocyte, Inc. (ECYT) Reports Q4 Loss of $0.10
April 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8253661 for the full story. Read More
from StreetInsider.com News Articles
Active Stocks In The Latest Trading Session: (NYSE: EXM), (NASDAQ: ECYT)
March 29, 2013
from ACCESSWIRE
Unusual 11 Mid-Day Movers 03/27: (CHCI) (UEPS) (UTSI) Higher; (ASTM) (EVBS) (CLF) Lower
March 27, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8215168 for the full story. Read More
from StreetInsider.com News Articles
UPDATE: Wedbush Raises PT on Endocyte on Significant Catalysts Ahead
March 27, 2013
In a report published Wednesday, Wedbush analyst Gregory R. Wade reiterated an Outperform rating on Endocyte (NASDAQ: ECYT ), and raised the price target from $16.00 to $20.00. In the report, Wade... Read More
category Benzinga , Wedbush , ECYT , and 3 more.
from Latest Articles from Benzinga.com
Wedbush Sees a Near Double in Endocyte (ECYT)
March 27, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8214414 for the full story. Read More
from StreetInsider.com News Articles
Baird Upgrades Endocyte (ECYT) to Outperform
March 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8207985 for the full story. Read More
from StreetInsider.com News Articles
Endocyte (ECYT) Files $125M Mixed Shelf
March 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8192938 for the full story. Read More
from StreetInsider.com News Articles
Endocyte, Inc. (ECYT) Reports In-Line Q4 Loss of 2c/Share
February 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8129668 for the full story. Read More
from StreetInsider.com News Articles
Roth Capital Starts Endocyte (ECYT) at Buy
February 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8105059 for the full story. Read More
from StreetInsider.com News Articles
UPDATE: Credit Suisse Initiates Endocyte at Outperform Ahead of Catalysts
January 15, 2013
Credit Suisse initiated coverage on Endocyte, Inc. (NASDAQ: ECYT ) with a Outperform rating and a $16.00 price target. Credit Suisse noted, "We anticipate significant stock appreciation ahead of key... Read More
category Benzinga , Initiation , Credit Suisse , and 5 more.
from Latest Articles from Benzinga.com
Credit Suisse Starts Endocyte (ECYT) at Outperform
January 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8008234 for the full story. Read More
from StreetInsider.com News Articles
4 Research Firms Generating Value Through New Drug Technology
January 14, 2013
category Pharmaceuticals
from Trefis
Dr. Lesley Russell Joins the Endocyte Board of Directors
January 08, 2013
Endocyte, Inc. (Nasdaq: ECYT ), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy in cancer and other... Read More
category Management , Benzinga , US29269A1025 , and 2 more.
from Latest Articles from Benzinga.com
3 Pharmaceutical Stocks to Buy Now
December 21, 2012
 Read More
category NYSE:WPI , NASDAQ:ECYT , Stocks to Buy , and 1 more.
from InvestorPlace - Latest Headlines
Medidata (MDSO) Cloud Platform Selected for Use by Endocyte (ECYT)
December 14, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7948929 for the full story. Read More
from StreetInsider.com News Articles
Merck (MRK), Endocyte (ECYT) Says EMA Accepts Vintafolide MAA for Review
November 27, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7904572 for the full story. Read More
from StreetInsider.com News Articles
Summer Street Starts Endocyte (ECYT) at Buy
November 20, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7894151 for the full story. Read More
from StreetInsider.com News Articles
Endocyte (ECYT) Says CAELYX Supply Approved by CHMP; Enrolling in Ovarian Cancer Phase 3;
October 30, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7827296 for the full story. Read More
from StreetInsider.com News Articles
Endocyte (ECYT) Gets EC Orphan Drug Designation for Its Folic Acid Solution on Ovarian Cancer
September 27, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7754191 for the full story. Read More
from StreetInsider.com News Articles
Endocyte, Inc. (ECYT) Reports Q2 Loss of $0.15
August 02, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7627697 for the full story. Read More
from StreetInsider.com News Articles
Endocyte, Inc. (ECYT) Adds David Meek as Chief Commercial Officer
July 26, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7608111 for the full story. Read More
from StreetInsider.com News Articles
Endocyte, Inc. (ECYT) Tops Q1 EPS by 4c
May 10, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7426538 for the full story. Read More
from StreetInsider.com News Articles
Markets Surge As Home Construction Permits Soar
April 17, 2012
New permits for home construction climbed 4.5% in March to lift the markets to a sharply higher open with the Dow surging 133 points to 13,054. Nasdaq soared 37 points to 3025. Read More
category Market News
from MarketMinute.com Market Updates
Endocyte (ECYT) Sees Early Activity Again Following EC145 Agreement
April 17, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7349786 for the full story. Read More
from StreetInsider.com News Articles
Merck Updates: Partners With Endocyte; Propecia Gets New Virility Warnings
April 17, 2012
category Pharmaceuticals
from Trefis
Lightning Round: Endocyte, Bank of America, Arch Coal and More
April 16, 2012
Cramer makes the call on viewers' favorite stocks. Read More
category Investing/Stock Market/Stock Picks , Mad Money for Mobile , Investing/Stock Market
from CNBC.com News
Apple, Nasdaq Pressure Market
April 16, 2012
The stock market started the week off on a very soar note, particularly on the Nasdaq 100, as Apple Inc. (AAPL) pressured stocks all day and dropped a whopping 25.10 to under 600 at 580.13, just 2... Read More
from Harry's Hotline by Harry Boxer
Stocks to watch Tuesday: Coke, Goldman Sachs
April 16, 2012
Endocyte Inc., Johnson & Johnson, Coca-Cola Co., Goldman Sachs Group Inc. and US Bancorp are among the stocks that could see active trading on Tuesday. Read More
category Biotechnology , Retail , Financial Services , and 21 more.
from MarketWatch
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here